SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016616
Filing Date
2019-05-07
Accepted
2019-05-07 17:09:28
Documents
67
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acor-10q_20190331.htm 10-Q 1453776
2 EX-31.1 acor-ex311_7.htm EX-31.1 16243
3 EX-31.2 acor-ex312_8.htm EX-31.2 15768
4 EX-32.1 acor-ex321_6.htm EX-32.1 6691
5 EX-32.2 acor-ex322_9.htm EX-32.2 6909
  Complete submission text file 0001564590-19-016616.txt   6356121

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acor-20190331.xml EX-101.INS 1461725
7 XBRL TAXONOMY EXTENSION SCHEMA acor-20190331.xsd EX-101.SCH 46846
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acor-20190331_cal.xml EX-101.CAL 65041
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acor-20190331_def.xml EX-101.DEF 140271
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20190331_lab.xml EX-101.LAB 396329
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20190331_pre.xml EX-101.PRE 297920
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31938 | Film No.: 19804118
SIC: 2836 Biological Products, (No Diagnostic Substances)